Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Oncol.

Sec. Cancer Genetics

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1616441

The use of whole genome sequencing to study young patients with 100+ adenomas of the colon

Provisionally accepted
Aleksey  S TsukanovAleksey S Tsukanov1Sergey  I AchkasovSergey I Achkasov1Anna  N LoginovaAnna N Loginova1Vitaly  P ShubinVitaly P Shubin1Dmitry  Y PikunovDmitry Y Pikunov1*Nikolay  N ChekanovNikolay N Chekanov2Anastasiya  S SalomatinaAnastasiya S Salomatina2Konstantin  V SeverinovKonstantin V Severinov2
  • 1Ryzhikh National Medical Research Centre of Coloproctology, Moscow, Russia
  • 2"Biotechnology campus" LLC, Moscow, Russia

The final, formatted version of the article will be published soon.

Objective. Adenomatous polyposis syndrome (APS) is a rare hereditary disease characterized by the development of multiple (more than 20) adenomas of the colon with a high-risk of malignant transformation without surgical treatment. The most aggressive form of APS, with >100 polyps before the age of 45 years, is mostly caused by germline pathogenic variants in the APC gene but patients with germline variants in the MUTYH and, very rarely, in the SMAD4 and BMPR1A genes were also reported. Routine molecular testing methods, such as Sanger sequencing, multiplex ligation-dependent probe amplification (MLPA) or multigene NGS panels, may fail to detect pathogenic variants in non-coding regions. Patients and methods. DNA from blood samples of 10 patients (with age of APS manifestation between 15 and 45 years) with over 100 adenomatous colonic polyps identified by endoscopic examination was subjected to whole genome sequencing (WGS). Prior genetic testing did not detect any germline pathogenic variants in the APC and MUTYH coding exons in these patients. Results. Pathogenic and likely pathogenic germline variants in non-coding regions of genes were identified in 3 patients. Two unrelated patients had the same c.-190G>A (rs879253785) in the 1B promoter of the APC gene (NM_001127511.3), while the third patient had a c.-152-2A>G variant in the BMPR1A gene (NM_004329.3). Using standard NGS panels or whole exome sequencing (WES) would not have detected these variants. Conclusion. Our results demonstrate that WGS is a useful genetic testing method for young patients with over 100 adenomatous colonic polyps, when routine DNA diagnostic methods fail to establish the genetic cause of the disease.

Keywords: Familial Adenomatous Polyposis, APC, BMPR1A, Juvenile polyposis syndrome, whole genome sequencing

Received: 22 Apr 2025; Accepted: 30 Sep 2025.

Copyright: © 2025 Tsukanov, Achkasov, Loginova, Shubin, Pikunov, Chekanov, Salomatina and Severinov. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Dmitry Y Pikunov, pikunov.gnck@mail.ru

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.